• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Biotech HOLDRs

Biotech HOLDRs

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. BBH Stays Unhedged With New Global Fund

    BBH Global Core Select manager Tim Hartch avoids currency hedging so he can eliminate complexities in managing the portfolio and maintain a focus on stable underlying businesses.

  2. Hartch: BBH Fund Closure Protecting Against Future Flows

    BBH Core Select comanager Tim Hartch and his team recently closed the fund to better manage the strategy through organic growth than though the anticipated inflows.

  3. Timothy Hartch and Michael Keller, BBH Core Select

    Skittish about stocks? The managers of BBH Core Select have carefully constructed a 30-name portfolio that has been more stable than the market.

  4. BBH's Core Focus on Google

    By homing in on Google's core revenue-generating operations, BBH manager Tim Hartch sees a value proposition in the online firm, with Google's other investments being gravy.

  5. UPDATE: Euro rallies as German bunds continue rout

    UPDATE: Euro rallies as German bunds continue rout

  6. UPDATE: Euro rises as U.S. productivity falls

    UPDATE: Euro rises as U.S. productivity falls

  7. Ultimate Stock-Pickers: Top 10 Buys and Sells

    Top managers continue to find opportunities for some new-money purchases, while taking full advantage of a rising stock market to book gains in shares trading above their fair value estimates.

  8. BBH Rolls Out Its First Mutual Fund Since 2002

    Brown Brothers Harriman launches a concentrated large-blend fund investing in U.S. and foreign stocks; Vanguard reopens its Capital Opportunity fund to individual investors; Franklin Templeton rolls out an emerging-markets bond fund; USAA seeks permission to create actively managed ETFs; and ...

Upcoming Events

©2014 Morningstar Advisor. All right reserved.